Fig 1. Venn diagrams showing overlapping and non-overlapping targets of hit compounds.

225 compounds had IC₅₀’s below 1 μM against at least one kinase (left); a subset of 72 compounds had IC₅₀’s below 100 nM against at least one kinase (right).